je.st
news
Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial
2015-10-19 19:30:37| Food - Topix.net
Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.
Tags: iii
trial
phase
disease
Category:Food and Related Products